chloroacetaldehyde has been researched along with Lung Neoplasms in 3 studies
Lung Neoplasms: Tumors or cancer of the LUNG.
Excerpt | Relevance | Reference |
---|---|---|
" Similar dose-response curves were found for both metabolites." | 1.30 | Ifosfamide cytotoxicity on human tumor and renal cells: role of chloroacetaldehyde in comparison to 4-hydroxyifosfamide. ( Brüggemann, SK; Kisro, J; Wagner, T, 1997) |
" As compared with the values obtained on day 1, on day 5 the terminal half-life and AUC values determined for IF were reduced by 30% (6." | 1.29 | Comparative pharmacokinetics of ifosfamide, 4-hydroxyifosfamide, chloroacetaldehyde, and 2- and 3-dechloroethylifosfamide in patients on fractionated intravenous ifosfamide therapy. ( Kurowski, V; Wagner, T, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kurowski, V | 1 |
Wagner, T | 2 |
Brüggemann, SK | 1 |
Kisro, J | 1 |
Henning, T | 1 |
Brischwein, M | 1 |
Baumann, W | 1 |
Ehret, R | 1 |
Freund, I | 1 |
Kammerer, R | 1 |
Lehmann, M | 1 |
Schwinde, A | 1 |
Wolf, B | 1 |
3 other studies available for chloroacetaldehyde and Lung Neoplasms
Article | Year |
---|---|
Comparative pharmacokinetics of ifosfamide, 4-hydroxyifosfamide, chloroacetaldehyde, and 2- and 3-dechloroethylifosfamide in patients on fractionated intravenous ifosfamide therapy.
Topics: Acetaldehyde; Adult; Aged; Carcinoma, Bronchogenic; Chromatography, Gas; Chromatography, High Pressu | 1993 |
Ifosfamide cytotoxicity on human tumor and renal cells: role of chloroacetaldehyde in comparison to 4-hydroxyifosfamide.
Topics: Acetaldehyde; Carcinoma, Non-Small-Cell Lung; Cell Survival; Cells, Cultured; Dose-Response Relation | 1997 |
Approach to a multiparametric sensor-chip-based tumor chemosensitivity assay.
Topics: Acetaldehyde; Antibiotics, Antineoplastic; Biosensing Techniques; Breast Neoplasms; Doxorubicin; Dru | 2001 |